(Q35187217)

7 August 2017

1 reference

title

Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases (English)

1 reference

7 August 2017

1

Wolfram Bode

1 reference

7 August 2017

Klaus Maskos

2

1 reference

7 August 2017

1 June 2003

1 reference

7 August 2017

1 reference

7 August 2017

384

1 reference

7 August 2017

6

1 reference

7 August 2017

863-872

1 reference

Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme

7 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Structural properties of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Tissue inhibitors of metalloproteinases: evolution, structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Matrix metalloproteinases: a tail of a frog that became a prince

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Crystal structures of matrilysin-inhibitor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

A matrix metalloproteinase expressed on the surface of invasive tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Structural basis of the adaptive molecular recognition by MMP9

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

MMP inhibitors: glimmers of hope amidst clinical failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Preclinical development of metalloproteasis inhibitors in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

The NMR structure of the inhibited catalytic domain of human stromelysin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Development of matrix metalloproteinase inhibitors in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Raster3D: photorealistic molecular graphics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Tissue inhibitors of matrix metalloendopeptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Relating matrix metalloproteinase structure to function: why the "hemopexin" domain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Gelatinase B: a tuner and amplifier of immune functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

CA-MMP: a matrix metalloproteinase with a novel cysteine array, but without the classic cysteine switch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Furin-dependent intracellular activation of the human stromelysin-3 zymogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Cysteine array matrix metalloproteinase (CA-MMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Structural implications for the role of the N terminus in the ‘superactivation’ of collagenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in brea

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

On the size of the active site in proteases. I. Papain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

1.56 A structure of mature truncated human fibroblast collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Structure of human neutrophil collagenase reveals large S1' specificity pocket

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

How matrix metalloproteinases regulate cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

NMR structure of tissue inhibitor of metalloproteinases-1 implicates localized induced fit in recognition of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.097

21 January 2018

Identifiers

DOI

10.1515/BC.2003.097

1 reference

7 August 2017

1 reference

PubMed ID

12887053